X4 Pharmaceuticals Inc —— 季度现金流量表 (NASDAQ:XFOR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 146.45 M130.01 M105.17 M163.56 M290.46 M 负债总额 124.3 M107.07 M101.2 M101.94 M104.17 M 权益总额 22.15 M22.94 M3.97 M61.62 M186.29 M 负债及股东权益总额 146.45 M130.01 M105.17 M163.56 M290.46 M 总债务 77.66 M77.41 M77.18 M76.3 M75.99 M 净债务 -24.44 M-9.59 M14.18 M-45.91 M-177.01 M

新闻

Stifel重申X4 Pharmaceuticals股票评级,临床试验进展顺利

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

X4 Pharmaceuticals在Leerink全球医疗保健会议上宣布战略转向罕见血液病领域

X4 Pharmaceuticals at Leerink Global Healthcare Conference: Strategic Shift to Rare Hematology

Guggenheim initiates X4 Pharmaceuticals stock with buy rating

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

欧洲药品管理局专家组支持mavorixafor用于超罕见WHIM综合征治疗

EMA panel backs mavorixafor for ultra-rare WHIM syndrome

Vericel Corporation (VCEL) Matches Q4 Earnings Estimates

X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy